PMCTPharmaCountry
    Inicio

Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#transdermal patch ×

UPDATED
Actualizaciones regulatorias
10 sept 2026•1 min de lectura
FDA Approves TRANSDERM SCOP (NDA017874) Transdermal Scopolamine Patch
The FDA has approved the prescription transdermal patch TRANSDERM SCOP, containing 1 mg scopolamine per 72 hr, under NDA 017874. Baxter Healthcare is the manufacturer.
UPDATED
Actualizaciones regulatorias
3 sept 2026•1 min de lectura
FDA Approves ANDA210272 for Buprenorphine Transdermal Patch
The FDA has approved application ANDA210272 for a buprenorphine transdermal patch, covering five dosage strengths and requiring a REMS program.